Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations
Aim The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations. Methods The sample consisted of 501 ED patients admit...
Gespeichert in:
| Veröffentlicht in: | Eating and weight disorders 2016-09, Vol.21 (3), p.395-402 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 402 |
|---|---|
| container_issue | 3 |
| container_start_page | 395 |
| container_title | Eating and weight disorders |
| container_volume | 21 |
| creator | Garner, David M. Anderson, Michael L. Keiper, Christopher D. Whynott, Rachel Parker, Lisa |
| description | Aim
The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations.
Methods
The sample consisted of 501 ED patients admitted to an adult partial hospitalization or adolescent residential program. Patients were divided into two diagnostic groups: anorexia nervosa (AN = 287) and bulimia nervosa (BN = 214), as well as two age groups: adults (age ≥18;
N
= 318) and adolescents (age |
| doi_str_mv | 10.1007/s40519-016-0253-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1816634613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1816634613</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-146696a7c124a7bef31c509f9bbc41bbb972073e5aeb7ce5a9a186cd8a77bf153</originalsourceid><addsrcrecordid>eNp1UU9rFzEQDaLY-tMP4EUCXrxEJ5tsduNNSrWFgh70HPJntqbsJj-T3UL99KZsVRA8zZB5703mPUJecnjLAYZ3VULPNQOuGHS9YPCInPJeA-Od6h63nneSSQ36hDyr9QZAciHgKTnp1ChACjglP7_UO_89ryUfo6cLhujtGnOqNCZqwzav1KbQujxj9ZhWim2ermmINZeApb6nfo6p0WZ6LNav0SO9be9bpXgbAyaPzNmKgRb0eVkwhX3Dc_JksnPFFw_1QL59PP96dsGuPn-6PPtwxbwU48q4VEorO_h2jB0cToL7HvSknfOSO-f00MEgsLfoBt-KtnxUPox2GNzEe3Egb3bdY8k_NqyrWWI7ZZ5twrxVw0eulJCqeXMgr_-B3uStpPY700kYZXNbjw3Fd5QvudaCkzmWuNhyZziY-2DMHoxpwZj7YAw0zqsH5c01l_8wfifRAN0OqG2UrrH8Xf1_1V8RRprr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2408451998</pqid></control><display><type>article</type><title>Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Garner, David M. ; Anderson, Michael L. ; Keiper, Christopher D. ; Whynott, Rachel ; Parker, Lisa</creator><creatorcontrib>Garner, David M. ; Anderson, Michael L. ; Keiper, Christopher D. ; Whynott, Rachel ; Parker, Lisa</creatorcontrib><description>Aim
The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations.
Methods
The sample consisted of 501 ED patients admitted to an adult partial hospitalization or adolescent residential program. Patients were divided into two diagnostic groups: anorexia nervosa (AN = 287) and bulimia nervosa (BN = 214), as well as two age groups: adults (age ≥18;
N
= 318) and adolescents (age <18;
N
= 183).
Results
Forty-one different psychotropic medications (891 prescriptions in all) were prescribed for 429 patients. Overall, 85.6 % of the total sample reported using one or more psychotropic medications. Of 429 patients using any medications, 46.9 % were on two or more, 25.3 % on three or more, and 11.0 % four or more. Antidepressants were most commonly prescribed (89.5 % of those on medication) with no significant differences in usage patterns based on diagnosis. However, there was greater medication use among adults (89.6 %) compared to adolescents (78.7 %). Results indicate psychotropic medication prescription is more widespread in a clinical sample than in an earlier report screening for osteoporosis in AN women.
Discussion
Treatment recommendations suggest medication should not be the primary treatment for EDs and empirical evidence demonstrates their ineffectiveness in AN. Nevertheless, there were no differences in frequency found between diagnostic groups, confirming little relationship between evidence-based recommendations and actual clinical use for those referred to a specialized ED treatment facility. This study adds new evidence regarding age-based comparisons of psychotropic prescription frequency in clinical EDs and comparison between AN and BN which has not been examined in earlier studies.</description><identifier>ISSN: 1124-4909</identifier><identifier>EISSN: 1590-1262</identifier><identifier>DOI: 10.1007/s40519-016-0253-0</identifier><identifier>PMID: 26830430</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adolescent ; Adult ; Adults ; Age ; Antidepressive Agents - therapeutic use ; Antipsychotic Agents - therapeutic use ; Child ; Eating disorders ; Evidence-Based Medicine ; Feeding and Eating Disorders - drug therapy ; Female ; Humans ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Original Article ; Psychiatry ; Psychotropic drugs ; Psychotropic Drugs - therapeutic use ; Teenagers ; Treatment Outcome ; Young Adult</subject><ispartof>Eating and weight disorders, 2016-09, Vol.21 (3), p.395-402</ispartof><rights>Springer International Publishing Switzerland 2016</rights><rights>Springer International Publishing Switzerland 2016.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-146696a7c124a7bef31c509f9bbc41bbb972073e5aeb7ce5a9a186cd8a77bf153</citedby><cites>FETCH-LOGICAL-c438t-146696a7c124a7bef31c509f9bbc41bbb972073e5aeb7ce5a9a186cd8a77bf153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40519-016-0253-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40519-016-0253-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27933,27934,41497,42566,51328</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26830430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garner, David M.</creatorcontrib><creatorcontrib>Anderson, Michael L.</creatorcontrib><creatorcontrib>Keiper, Christopher D.</creatorcontrib><creatorcontrib>Whynott, Rachel</creatorcontrib><creatorcontrib>Parker, Lisa</creatorcontrib><title>Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations</title><title>Eating and weight disorders</title><addtitle>Eat Weight Disord</addtitle><addtitle>Eat Weight Disord</addtitle><description>Aim
The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations.
Methods
The sample consisted of 501 ED patients admitted to an adult partial hospitalization or adolescent residential program. Patients were divided into two diagnostic groups: anorexia nervosa (AN = 287) and bulimia nervosa (BN = 214), as well as two age groups: adults (age ≥18;
N
= 318) and adolescents (age <18;
N
= 183).
Results
Forty-one different psychotropic medications (891 prescriptions in all) were prescribed for 429 patients. Overall, 85.6 % of the total sample reported using one or more psychotropic medications. Of 429 patients using any medications, 46.9 % were on two or more, 25.3 % on three or more, and 11.0 % four or more. Antidepressants were most commonly prescribed (89.5 % of those on medication) with no significant differences in usage patterns based on diagnosis. However, there was greater medication use among adults (89.6 %) compared to adolescents (78.7 %). Results indicate psychotropic medication prescription is more widespread in a clinical sample than in an earlier report screening for osteoporosis in AN women.
Discussion
Treatment recommendations suggest medication should not be the primary treatment for EDs and empirical evidence demonstrates their ineffectiveness in AN. Nevertheless, there were no differences in frequency found between diagnostic groups, confirming little relationship between evidence-based recommendations and actual clinical use for those referred to a specialized ED treatment facility. This study adds new evidence regarding age-based comparisons of psychotropic prescription frequency in clinical EDs and comparison between AN and BN which has not been examined in earlier studies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Adults</subject><subject>Age</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Child</subject><subject>Eating disorders</subject><subject>Evidence-Based Medicine</subject><subject>Feeding and Eating Disorders - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Psychiatry</subject><subject>Psychotropic drugs</subject><subject>Psychotropic Drugs - therapeutic use</subject><subject>Teenagers</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>1124-4909</issn><issn>1590-1262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1UU9rFzEQDaLY-tMP4EUCXrxEJ5tsduNNSrWFgh70HPJntqbsJj-T3UL99KZsVRA8zZB5703mPUJecnjLAYZ3VULPNQOuGHS9YPCInPJeA-Od6h63nneSSQ36hDyr9QZAciHgKTnp1ChACjglP7_UO_89ryUfo6cLhujtGnOqNCZqwzav1KbQujxj9ZhWim2ermmINZeApb6nfo6p0WZ6LNav0SO9be9bpXgbAyaPzNmKgRb0eVkwhX3Dc_JksnPFFw_1QL59PP96dsGuPn-6PPtwxbwU48q4VEorO_h2jB0cToL7HvSknfOSO-f00MEgsLfoBt-KtnxUPox2GNzEe3Egb3bdY8k_NqyrWWI7ZZ5twrxVw0eulJCqeXMgr_-B3uStpPY700kYZXNbjw3Fd5QvudaCkzmWuNhyZziY-2DMHoxpwZj7YAw0zqsH5c01l_8wfifRAN0OqG2UrrH8Xf1_1V8RRprr</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Garner, David M.</creator><creator>Anderson, Michael L.</creator><creator>Keiper, Christopher D.</creator><creator>Whynott, Rachel</creator><creator>Parker, Lisa</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations</title><author>Garner, David M. ; Anderson, Michael L. ; Keiper, Christopher D. ; Whynott, Rachel ; Parker, Lisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-146696a7c124a7bef31c509f9bbc41bbb972073e5aeb7ce5a9a186cd8a77bf153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Adults</topic><topic>Age</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Child</topic><topic>Eating disorders</topic><topic>Evidence-Based Medicine</topic><topic>Feeding and Eating Disorders - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Psychiatry</topic><topic>Psychotropic drugs</topic><topic>Psychotropic Drugs - therapeutic use</topic><topic>Teenagers</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garner, David M.</creatorcontrib><creatorcontrib>Anderson, Michael L.</creatorcontrib><creatorcontrib>Keiper, Christopher D.</creatorcontrib><creatorcontrib>Whynott, Rachel</creatorcontrib><creatorcontrib>Parker, Lisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Eating and weight disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garner, David M.</au><au>Anderson, Michael L.</au><au>Keiper, Christopher D.</au><au>Whynott, Rachel</au><au>Parker, Lisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations</atitle><jtitle>Eating and weight disorders</jtitle><stitle>Eat Weight Disord</stitle><addtitle>Eat Weight Disord</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>21</volume><issue>3</issue><spage>395</spage><epage>402</epage><pages>395-402</pages><issn>1124-4909</issn><eissn>1590-1262</eissn><abstract>Aim
The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations.
Methods
The sample consisted of 501 ED patients admitted to an adult partial hospitalization or adolescent residential program. Patients were divided into two diagnostic groups: anorexia nervosa (AN = 287) and bulimia nervosa (BN = 214), as well as two age groups: adults (age ≥18;
N
= 318) and adolescents (age <18;
N
= 183).
Results
Forty-one different psychotropic medications (891 prescriptions in all) were prescribed for 429 patients. Overall, 85.6 % of the total sample reported using one or more psychotropic medications. Of 429 patients using any medications, 46.9 % were on two or more, 25.3 % on three or more, and 11.0 % four or more. Antidepressants were most commonly prescribed (89.5 % of those on medication) with no significant differences in usage patterns based on diagnosis. However, there was greater medication use among adults (89.6 %) compared to adolescents (78.7 %). Results indicate psychotropic medication prescription is more widespread in a clinical sample than in an earlier report screening for osteoporosis in AN women.
Discussion
Treatment recommendations suggest medication should not be the primary treatment for EDs and empirical evidence demonstrates their ineffectiveness in AN. Nevertheless, there were no differences in frequency found between diagnostic groups, confirming little relationship between evidence-based recommendations and actual clinical use for those referred to a specialized ED treatment facility. This study adds new evidence regarding age-based comparisons of psychotropic prescription frequency in clinical EDs and comparison between AN and BN which has not been examined in earlier studies.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>26830430</pmid><doi>10.1007/s40519-016-0253-0</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1124-4909 |
| ispartof | Eating and weight disorders, 2016-09, Vol.21 (3), p.395-402 |
| issn | 1124-4909 1590-1262 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1816634613 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Adolescent Adult Adults Age Antidepressive Agents - therapeutic use Antipsychotic Agents - therapeutic use Child Eating disorders Evidence-Based Medicine Feeding and Eating Disorders - drug therapy Female Humans Male Medicine Medicine & Public Health Middle Aged Original Article Psychiatry Psychotropic drugs Psychotropic Drugs - therapeutic use Teenagers Treatment Outcome Young Adult |
| title | Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T03%3A00%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychotropic%20medications%20in%20adult%20and%20adolescent%20eating%20disorders:%20clinical%20practice%20versus%20evidence-based%20recommendations&rft.jtitle=Eating%20and%20weight%20disorders&rft.au=Garner,%20David%20M.&rft.date=2016-09-01&rft.volume=21&rft.issue=3&rft.spage=395&rft.epage=402&rft.pages=395-402&rft.issn=1124-4909&rft.eissn=1590-1262&rft_id=info:doi/10.1007/s40519-016-0253-0&rft_dat=%3Cproquest_cross%3E1816634613%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2408451998&rft_id=info:pmid/26830430&rfr_iscdi=true |